Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News PolyPid Ltd PYPD

Healthcare Biotechnology
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.

Recent & Breaking News (NDAQ:PYPD)

PolyPid to Participate in Three Upcoming Fall Investor Conferences

GlobeNewswire September 3, 2024

PolyPid Provides Corporate Update and Reports Second Quarter 2024 Financial Results

GlobeNewswire August 14, 2024

PolyPid Announces Private Placement for Up to $14 Million in Gross Proceeds

GlobeNewswire August 1, 2024

PolyPid to Report Second Quarter 2024 Financial Results and Operational Highlights on August 14, 2024

GlobeNewswire July 31, 2024

PolyPid Hosts KOL Call to Discuss Significant Unmet Medical Need in Surgical Site Infections Prevention and Provides Update on its Ongoing SHIELD II Phase 3 Trial

GlobeNewswire June 18, 2024

PolyPid to Host Virtual KOL Event on June 17, 2024, and Provide an Update on the Company's Ongoing D-PLEX₁₀₀ Phase 3 Trial

GlobeNewswire June 10, 2024

PolyPid Provides Corporate Update and Reports First Quarter 2024 Financial Results

GlobeNewswire May 8, 2024

PolyPid to Participate in Citizens JMP Life Sciences Conference

GlobeNewswire May 1, 2024

PolyPid Announces Enrollment of 200th Patient in Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections

GlobeNewswire April 30, 2024

PolyPid to Report First Quarter 2024 Financial Results and Operational Highlights on May 8, 2024

GlobeNewswire April 24, 2024

PolyPid to Participate in Barclays 26th Annual Global Healthcare Conference

GlobeNewswire February 28, 2024

PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire February 14, 2024

PolyPid Announces Enrollment of the 100th Patient in the Ongoing SHIELD II Phase 3 Trial

GlobeNewswire February 12, 2024

PolyPid to Report Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights on February 14, 2024

GlobeNewswire January 31, 2024

PolyPid Announces Private Placement for $16 Million in Gross Proceeds

GlobeNewswire January 4, 2024

PolyPid Provides Corporate Update and Reports Third Quarter 2023 Financial Results

GlobeNewswire November 8, 2023

PolyPid Announces the Addition of Dr. Nurit Tweezer-Zaks to its Board of Directors

GlobeNewswire November 7, 2023

PolyPid to Report Third Quarter 2023 Financial Results and Operational Highlights on November 8, 2023

GlobeNewswire November 1, 2023

PolyPid Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

GlobeNewswire October 11, 2023

PolyPid Announces Presentation at the American College of Surgeons Clinical Congress 2023

GlobeNewswire October 9, 2023